Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous Non-SCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy

Autor: Hochmair, Maximilian, Schenker, Michael, Cobo Dols, Manuel, Kim, Tae Min, Ozyilkan, Ozgur, Smagina, Maria, Viktoriya, Leonova, Kato, Terufumi, Fedenko, Alexander, De Angelis, Flavia, Rittmeyer, Achim, Gray, Jhanelle E., Greystoke, Alastair, Aggarwal, Himani, Huang, Qinlei, Zhao, Bin, Lara-Guerra, Humberto, Nadal, Ernest

Publikováno v: In Journal of Thoracic Oncology October 2024

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Autor: Adamchuk, Grigory, Ahn, Myung-Ju, Alexandru, Aurelia, Altundag, Ozden, Alyasova, Anna, Andrusenko, Orest, Aoe, Keisuke, Araujo, Antonio, Aren, Osvaldo, Arrieta Rodriguez, Oscar, Ativitavas, Touch, Avendano, Oscar, Barata, Fernando, Barrios, Carlos Henrique, Beato, Carlos, Bergstrom, Per, Betticher, Daniel, Bolotina, Larisa, Bondarenko, Igor, Botha, Michiel, Buddu, Sayeuri, Caglevic, Christian, Cardona, Andres, Castro, Gilberto, Jr, Castro, Hugo, Cay Senler, Filiz, Cerny, Carlos Alexandre Sydow, Cesas, Alvydas, Chan, Gee-Chen, Chang, Jianhua, Chen, Gongyan, Chen, Xi, Cheng, Susanna, Cheng, Ying, Cherciu, Nelly, Chiu, Chao-Hua, Cho, Byoung Chul, Cicenas, Saulius, Ciurescu, Daniel, Cohen, Graham, Costa, Marcos Andre, Danchaivijitr, Pongwut, De Angelis, Flavia, de Azevedo, Sergio Jobim, Dediu, Mircea, Deliverski, Tsvetan, De Marchi, Pedro Rafael Martins, de The Bustamante Valles, Flor, Ding, Zhenyu, Doganov, Boyan, Dreosti, Lydia, Duarte, Ricardo, Edusma-Dy, Regina, Emelyanov, Sergey, Erman, Mustafa, Fan, Yun, Fein, Luis, Feng, Jifeng, Fenton, David, Fernandes, Gustavo, Ferreira, Carlos, Franke, Fabio Andre, Freitas, Helano, Fujisaka, Yasuhito, Galindo, Hector, Galvez, Christina, Ganea, Doina, Gil, Nuno, Girotto, Gustavo, Goker, Erdem, Goksel, Tuncay, Gomez Aubin, Gonzalo, Gomez Wolff, Luis, Griph, Hakan, Gumus, Mahmut, Hall, Jacqueline, Hart, Gregory, Havel, Libor, He, Jianxing, He, Yong, Hernandez Hernandez, Carlos, Hespanhol, Venceslau, Hirashima, Tomonori, Ho, Chung Man James, Horiike, Atsushi, Hosomi, Yukio, Hotta, Katsuyuki, Hou, Mei, How, Soon Hin, Hsia, Te-Chun, Hu, Yi, Ichiki, Masao, Imamura, Fumio, Ivashchuk, Oleksandr, Iwamoto, Yasuo, Jaal, Jana, Jassem, Jacek, Jordaan, Christa, Juergens, Rosalyn Anne, Kaen, Diego, Kalinka-Warzocha, Ewa, Karaseva, Nina, Karaszewska, Boguslawa, Kazarnowicz, Andrzej, Kasahara, Kazuo, Katakami, Nobuyuki, Kato, Terufumi, Kawaguchi, Tomoya, Kim, Joo Hang, Kishi, Kazuma, Kolek, Vitezslav, Koleva, Marchela, Kolman, Petr, Koubkova, Leona, Kowalyszyn, Ruben, Kowalski, Dariusz, Koynov, Krassimir, Ksienski, Doran, Kubota, Kaoru, Kudaba, Iveta, Kurata, Takayasu, Kuusk, Gerli, Kuzina, Lyudmila, Laczo, Ibolya, Ladrera, Guia Elena Imelda, Laktionov, Konstantin, Landers, Gregory, Lazarev, Sergey, Lerzo, Guillermo, Lesniewski Kmak, Krzysztof, Li, Wei, Liam, Chong Kin, Lifirenko, Igor, Lipatov, Oleg, Liu, Xiaoqing, Liu, Zhe, Lo, Sing Hung, Lopes, Valeria, Lopez, Karla, Lu, Shun, Martinengo, Gaston, Mas, Luis, Matrosova, Marina, Micheva, Rumyana, Milanova, Zhasmina, Miron, Lucian, Mok, Tony, Molina, Matias, Murakami, Shuji, Nakahara, Yasuharu, Nguyen, Tien Quang, Nishimura, Takashi, Ochsenbein, Adrian, Ohira, Tatsuo, Ohman, Ronny, Ong, Choo Khoon, Ostoros, Gyula, Ouyang, Xuenong, Ovchinnikova, Elena, Ozyilkan, Ozgur, Petruzelka, Lubos, Pham, Xuan Dung, Picon, Pablo, Piko, Bela, Poltoratsky, Artem, Ponomarova, Olga, Popelkova, Patrice, Purkalne, Gunta, Qin, Shukui, Ramlau, Rodryg, Rappaport, Bernardo, Rey, Felipe, Richardet, Eduardo, Roubec, Jaromir, Ruff, Paul, Rusyn, Andrii, Saka, Hideo, Salas, Jorge, Sandoval, Mario, Santos, Lucas, Sawa, Toshiyuki, Seetalarom, Kasan, Seker, Mesut, Seki, Nobuhiko, Seolwane, Freddy, Shepherd, Lucinda, Shevnya, Sergii, Shimada, Andrea Kazumi, Shparyk, Yaroslav, Sinielnikov, Ivan, Sirbu, Daniela, Smaletz, Oren, Soares, Joao Paulo Holanda, Sookprasert, Aumkhae, Speranza, Giovanna, Srimuninnimit, Vichien, Sriuranpong, Virote, Stara, Zinaida, Su, Wu-Chou, Sugawara, Shunichi, Szpak, Waldemar, Takahashi, Kazuhisa, Takigawa, Nagio, Tanaka, Hiroshi, Tan Chun Bing, Jerry, Tang, Qiyou, Taranov, Pavel, Tejada, Hermes, Tho, Lye Mun, Torii, Yoshitaro, Trukhyn, Dmytro, Turdean, Maria, Turna, Hande, Ursol, Grygoriy, Vanasek, Jaroslav, Varela, Mirta, Vallejo, Marcela, Vera, Luis, Victorino, Ana-Paula, Vlasek, Tomas, Vynnychenko, Ihor, Wang, Buhai, Wang, Jie, Wang, Kai, Wu, Yilong, Yamada, Kazuhiko, Yang, Chih-Hsin, Yokoyama, Takuma, Yokoyama, Toshihide, Yoshioka, Hiroshige, Yumuk, Fulden, Zambrano, Angela, Zarba, Juan Jose, Zarubenkov, Oleg, Zemaitis, Marius, Zhang, Li, Zhang, Xin, Zhao, Jun, Zhou, Caicun, Zhou, Jianying, Zhou, Qing, Zippelius, Alfred, Mok, Tony S K, Wu, Yi-Long, Kowalski, Dariusz M, Turna, Hande Z, Laktionov, Konstantin K, Lubiniecki, Gregory M, Zhang, Jin, Kush, Debra, Lopes, Gilberto

Publikováno v: In The Lancet 4-10 May 2019 393(10183):1819-1830

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

Autor: Gandhi, Leena, Rodríguez-Abreu, Delvys, Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, De Angelis, Flávia, Domine, Manuel, Clingan, Philip, Hochmair, Maximilian J, Powell, Steven F, Cheng, Susanna Y-S, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Hui, Rina, Garon, Edward B, Boyer, Michael, Rubio-Viqueira, Belén, Novello, Silvia, Kurata, Takayasu, Gray, Jhanelle E, Vida, John, Wei, Ziwen, Yang, Jing, Raftopoulos, Harry, Pietanza, M Catherine, Garassino, Marina C, KEYNOTE-189 Investigators, Ocak, Sebahat

Publikováno v: The New England Journal of Medicine, 378, 22, pp. 2078-2092
The New England journal of medicine, Vol. 378, no. 22, p. 2078-2092 (2018)
The New England Journal of Medicine, 378, 2078-2092

Contains fulltext : 193627.pdf (Publisher’s version ) (Open Access) BACKGROUND: First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd80b53e7baf247aa76594edc561e889
https://hdl.handle.net/2066/193627

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Autor: Lacerte, Annie ^*, Bleau, Marie-Pier ^*, Castilloux, Jean-Francois, De-angelis, Flavia ^*, Desjardins, Pierre, Pavic, Michel ^*, Fulop, Tamas ^*

Publikováno v: In Blood 29 November 2018 132 Supplement 1:4213-4213